Global Sleeping Bruxism Treatment Market Research Report – Forecast to 2023

$4,450$6,250

The global sleeping bruxism treatment market is estimated to reach USD 168.74 million by 2023, from USD 118.02 million in 2017. The market is projected to register a CAGR of 6.1%, during the forecast period from 2018 to 2023.

Clear

Description

Sleep bruxism or nocturnal tooth grinding is a medical condition indicated by the clenching or grinding of teeth during sleep. The global sleeping bruxism treatment market is estimated to be driven by the increasing prevalence of sleep bruxism, growth in child population, changing lifestyle, and rising prevalence of obstructive sleep apnea.

Sleep bruxism is a sleep-related movement disorder, characterized by teeth grinding and jaw clenching during sleep. Since the past few years, it has been reported that the prevalence of the disease has increased. According to a study published by the Sleep Research Society, the general prevalence of sleep bruxism was estimated to range from 5.0 to 8.0% in 2016.

In the presence of such trends, the reported cases of headaches and tooth wear due to sleep bruxism are estimated to increase, thereby, mounting a negative impact on patients’ lives. Few effective ways to avoid such complications associated with the disease include the administration of medication, antidepressants, and muscle relaxants and wearing a mouth guard, besides others.

Thus, it is estimated that the increasing prevalence of sleep bruxism is subsequently increasing the demand for available therapeutic options involving antidepressants, muscle relaxants, and mouth guard, besides others. Conclusively, it is expected to provide favorable backgrounds for the market to grow during the forecast period.

However, factors such as the limited availability of treatment options and the high cost of custom fit night guards restrain the market growth. There is no specific cure, i.e., medications are not very effective for the treatment of sleep bruxism.

In such circumstances, it becomes important to manage the consequences of the disorder by available preventative measures, which involves the application of mandibular advancement devices, occlusal splints, stress management, drugs, occlusal splints, and others. A variety of medications such as anti-anxiety drugs and muscle relaxants are significantly employed in the treatment of sleep bruxism.

However, it is reported that such medication options come with the capping of side effects such as constipation, nausea, and muscle weakness, amongst others. Following the same course, it is evident that bruxism mouth-guards ground down with time during bruxism episodes.

Thus, it is estimated that available treatment options are not effective and incorporate side effects, making the patients reluctant to opt for available treatment options. This makes the market to lag during the study.

The global sleeping bruxism treatment market is estimated to reach USD 168.74 million by 2023, from USD 118.02 million in 2017. The market is projected to register a CAGR of 6.1%, during the forecast period from 2018 to 2023.

The sleeping bruxism treatment market comprises a variety of products. Based on the treatment type, the global market for sleeping bruxism treatments is segmented into primary bruxism and secondary bruxism. In primary bruxism, the chewing muscle activity and the autonomic nervous system is triggered by sleep arousals that eventually lead to teeth grinding.

The primary bruxism segment held the largest market share and is estimated to reach USD 168.74 million by 2023 from USD 118.02 million in 2017.
The global sleeping bruxism treatment market is segmented into diagnosis types which are inclusive of clinical examination, electromyographic methods, polysomnography, x-ray, and others.

Based on treatment, the global sleeping bruxism treatment market is segmented into dental approaches and medication. Dental approaches are the first line treatment given to the patients of sleeping bruxism and include splints and mouth guards. Thus, dental approaches account for the largest market share.

Based on the cause, the global sleeping bruxism treatment market is segmented into obstructive sleep apnea, sleep paralysis, Gastro-Esophageal Reflux Disease (GERD) malocclusion, and others. Obstructive sleep apnea is a sleep disorder that is characterized by repetitive breathing interruption in sleep.

According to the National Sleep Foundation, one in four people with obstructive sleep apnea, clench their teeth in sleep. Thus, obstructive sleep apnea is one of the major causes of sleeping bruxism and held the largest segment in 2017.

Based on its patient type, the global sleeping bruxism treatment market is segmented into pediatric and adult. Sleep bruxism occurs in children when they are taking a sound sleep and are under stress. Anger and nervousness lead to bruxism in kids.

According to KidsHealth, three out of every ten children suffer from sleep bruxism. Hence, the pediatric segment is estimated to hold the largest market share during the forecast period.

On the basis of end-user, the global sleeping bruxism treatment market is segmented into hospitals, dental clinics, and others. Dental clinics offer mouth guards, splints, orthodontic treatment and dental corrections. The increased use of dental approaches for teeth restoration accounts for a major market share of the sleep bruxism treatment market.

Key Players of Global Sleeping Bruxism Treatment Market

The key players for the sleeping bruxism treatment market include Randmark Dental Products, LLC, S4S Dental Laboratory, Ipsen Biopharmaceuticals, Inc, Merz Pharma GmbH & Co. KGaA, Carestream Dental, PLANMECA OY, and others.

Study Objectives
• To provide historical and forecast revenue of market segments and sub-segments with respect to regional markets and their countries
• To provide insights into factors influencing and affecting the market growth
• To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economic factors that influence the global sleeping bruxism treatment market

Target Audience
• Pharmaceutical and Medical Device Industries
• Potential Investors
• Medical Research Institutes
• Key Executives (CEO and COO) and Strategy Growth Managers
• Research Companies

Key Findings of Global Sleeping Bruxism Treatment Market

• The major market players in the global sleeping bruxism treatment market are Randmark Dental Products, LLC, S4S Dental Laboratory, and Ipsen Biopharmaceuticals, Inc

• Based on type, the primary bruxism segment held the largest market share and is estimated to reach USD 168.74 million by 2023 from USD 118.02 million in 2017.
• On the basis of treatment type, dental approaches account for the largest market share and are estimated to register a CAGR of 7.0% from 2018 to 2023

• Based on cause, the obstructive sleep apnea market is projected to reach USD 233.20 million by the end of 2023.

The report also covers regional analysis
Americas
• North America
o US
o Canada
• South America

Europe
• Western Europe
o Germany
o France
o UK
o Scandinavia

 Denmark
 Norway
 Sweden
 Finland
 Iceland

o Benelux Union
 Belgium
 Netherlands
 Luxembourg

o Italy
o Spain
o Switzerland
• Eastern Europe
Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of the Asia-Pacific
Middle East & Africa
• Middle East
• Africa

Global Sleeping Aids Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

Additional information

Publisher

Geography Covered

Date Published

Format

Table of Contents

1 Report Prologue
2 Market Introduction
2.1 Introduction
2.2 Assumptions & Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Data Triangulation
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing prevalence of sleep bruxism
4.2.2 Growing child population
4.2.3 Rising prevalence of obstructive sleep apnea
4.2.4 Lifestyle changes
4.2.5 Drivers Impact Analysis
4.3 Restraints
4.3.1 Limited availability of treatment options
4.3.2 High cost of custom fit night guards
4.3.3 Restraints Impact Analysis
4.4 Opportunity
4.4.1 Untapped markets of the Asia Pacific region
4.5 Macroeconomic Indicator
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D and Designing
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-Sales Review

5.2 Porter’s Five Forces Model
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitutes
5.2.5 Intensity of Rivalry
5.3 Investment Opportunities
5.4 Pricing Analysis
6 Global Sleeping Bruxism Treatment Market, by Type
6.1 Introduction
6.2 Primary Bruxism
6.3 Secondary Bruxism
7 Global Sleeping Bruxism Treatment Market, by Diagnosis
7.1 Introduction
7.1.1 Clinical Examination
7.1.2 X-rays
7.1.3 Electromyographic Methods
7.1.4 Polysomnography
8 Global Sleeping Bruxism Treatment Market, by Treatment Type
8.1 Introduction
8.2 Dental Approaches
8.3 Medication
9 Global Sleeping Bruxism Treatment Market, by Cause
9.1 Introduction
9.2 Obstructive Sleep Apnea
9.3 Gastroesophageal reflux disease (GERD)
9.4 Malocclusion
9.5 Sleep Paralysis
10 Global Sleeping Bruxism Treatment Market, by Patient Type
10.1 Introduction
10.2 Pediatric
10.3 Adult
11 Global Sleeping Bruxism Treatment Market, by End-User
11.1 Introduction
11.2 Hospitals
11.3 Dental Clinics
12 Global Sleeping Bruxism Treatment Market, by Region
12.1 Introduction
12.2 Americas
12.2.1 North America
12.2.1.1 US
12.2.1.2 Canada
12.2.2 South America
12.3 Europe
12.3.1 Introduction
12.3.2 Western Europe
12.3.2.1 Germany
12.3.2.2 France
12.3.2.3 U.K
12.3.2.4 Scandinavia
12.3.2.4.1 Denmark
12.3.2.4.2 Norway
12.3.2.4.3 Sweden
12.3.2.4.4 Finland
12.3.2.4.5 Iceland
12.3.2.5 Benelux Union
12.3.2.5.1 Belgium
12.3.2.5.2 Netherlands
12.3.2.5.3 Luxembourg
12.3.2.6 Italy
12.3.2.7 Spain
12.3.2.8 Switzerland
12.3.3 Eastern Europe
12.4 Asia Pacific
12.4.1 Introduction
12.4.2 China
12.4.3 India
12.4.4 Japan
12.4.5 South Korea
12.4.6 Rest of Asia Pacific
12.5 Middle East & Africa
12.5.1 Introduction
12.5.2 Middle East
12.5.3 Africa
13 Competitive Analysis
13.1 Introduction
14 Company Profiles
14.1 Ivoclar Vivadent AG
14.1.1 Company Overview
14.1.2 Financial Overview
14.1.3 Products Offering
14.1.4 Key Developments
14.1.5 SWOT Analysis
14.1.6 Key Strategy
14.2 Ipsen Biopharmaceuticals, Inc.
14.2.1 Company Overview
14.2.2 Financial Overview
14.2.3 Products Offering
14.2.4 Key Developments
14.2.5 SWOT Analysis
14.2.6 Key Strategy
14.3 Merz Pharma GmbH & Co. KGaA
14.3.1 Company Overview
14.3.2 Financial Overview
14.3.3 Products Offering
14.3.4 Key Developments
14.3.5 SWOT Analysis
14.3.6 Key Strategy
14.4 Carestream Dental
14.4.1 Company Overview
14.4.2 Financial Overview
14.4.3 Products Offering
14.4.4 Key Developments
14.4.5 SWOT Analysis
14.4.6 Key Strategy
14.5 Akervall Technologies Inc.
14.5.1 Company Overview
14.5.2 Financial Overview
14.5.3 Products Offering
14.5.4 Key Developments
14.5.5 SWOT Analysis
14.5.6 Key Strategy
14.6 PLANMECA OY
14.6.1 Company Overview
14.6.2 Financial Overview
14.6.3 Products Offering
14.6.4 Key Developments
14.6.5 SWOT Analysis
14.6.6 Key Strategy
14.7 Randmark Dental Products, LLC
14.7.1 Company Overview
14.7.2 Financial Overview
14.7.3 Products Offering
14.7.4 Key Developments
14.7.5 SWOT Analysis
14.7.6 Key Strategy
14.8 S4S Dental Laboratory
14.8.1 Company Overview
14.8.2 Financial Overview
14.8.3 Products Offering
14.8.4 Key Developments
14.8.5 SWOT Analysis
14.8.6 Key Strategy
14.9 Patterson Dental Supply, Inc.
14.9.1 Company Overview
14.9.2 Financial Overview
14.9.3 Products Offering
14.9.4 Key Developments
14.9.5 SWOT Analysis
14.9.6 Key Strategy
14.1 Henry Schein, Inc.
14.10.1 Company Overview
14.10.2 Financial Overview
14.10.3 Products Offering
14.10.4 Key Developments
14.10.5 SWOT Analysis
14.10.6 Key Strategy
14.11 Pfizer Inc.
14.11.1 Company Overview
14.11.2 Financial Overview
14.11.3 Products Offering
14.11.4 Key Developments
14.11.5 SWOT Analysis
14.11.6 Key Strategy
15 Appendix
15.1 Discussion Blue Print